SEC Form 4 · accession 0001179110-17-015677
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clive Meanwell
Officer — CEO · Director
Period of report
Dec 15, 2017
Accepted (ET)
Dec 19, 2017 · 7:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 15, 2017 | M | 200,920 | $19.36 | A | 587,652 | D | |
| Common StockF1,F2 | Dec 15, 2017 | S | 136,250 | $27.24 | D | 451,402 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F5,F3,F4 | $19.36 | Dec 15, 2017 | M | 200,920 | D | — | Feb 15, 2018 | Common Stock | 200,920 | 0 | D |
Explanation of responses
- F1Represents the weighted average sales price of the shares sold ranging from a low of $27.20 to a high of $27.51 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F2As a result of Dr. Meanwell's option exercise and purchase of a portion of the underlying shares as reported on this Form 4, Dr. Meanwell holds an additional 64,670 shares of common stock.
- F3This option vested in forty eight equal installments beginning on March 15, 2008.
- F4Options exercised due to their near term expiry.
- F5Not applicable.